Digestive Disease Week® (DDW) is the premier meeting for the GI professional. Every year it attracts approximately 15,000 physicians, researchers and academics from around the world who desire to stay up-to-date in the field.
The GI SAM series of online self-assessments modules is an interactive, intuitive product that will assess your current knowledge of specific gastroenterology- and hepatology-related topics. Offers CME credits and MOC points.
Quantitative Gastrointestinal and Psychological Traits Associated With Obesity and Response to Weight-Loss Therapy
March 1, 2015
We aimed to examine associations of quantitative gastrointestinal and psychological traits with obesity, and to validate the ability of these traits to predict responses of obese individuals to pharmacotherapy.
The FDA approved Qsymia(R) (phentermine and topiramate extended-release) capsule with a risk evaluation and mitigation strategy. The strategy was created to ensure that the benefits of Qsymia outweigh the increased risk of teratogenicity.
Ursodeoxycholic Acid and Diets Higher in Fat Prevent Gallbladder Stones During Weight Loss
July 3, 2014
Caroline S. Stokes and colleagues report in Clinical Gastroenterology and Hepatology that, during weight loss, ursodeoxycholic acid and/or higher dietary fat content appear to prevent formation of gallstones.
Support and Stimulate the Development and Delivery of New GI Technologies
Dec. 5, 2013
Lend your voice to the discussion on advancing GI practice through innovation. Key stakeholders in the development and delivery of new GI technologies will converge on San Francisco to address critical elements that impact the likelihood of success in the marketplace.
Exhaled VOC Concentrations Provide Childhood Obesity Clues
June 6, 2013
Concentrations of certain exhaled volatile organic compounds are significantly higher in obese children than in non-obese children, according to findings from a controlled study involving more than 100 children.
Providing Behavioral Therapy for Obesity? Understand the Medicare Benefit
April 2, 2013
Effective with dates of service on or after Nov. 29, 2011, Medicare covers intensive behavioral therapy for obesity for the prevention or early detection of illness or disability. Learn about the services the Medicare benefit covers, what a therapy visit should include, billing codes and more.
Manipulation of Gut Microbiota in Obesity Influences Metabolic Outcomes
Jan. 24, 2013
In a study published in Gut, Murphy, et al. studied two antimicrobial strategies for their impact on metabolic abnormalities in murine diet-induced obesity, finding that, while the gut microbiota is a realistic therapeutic target, the specificity of the antimicrobial agent employed is critical.
President Obama unveiled his fiscal year 2013 budget that sets funding priorities. In his budget, the NIH received $30.7 billion, which represents level funding. The president stated that although the funding is flat, new management policies will be put in place to increase the number of new grants by 7 percent.